Researchers presently investigating Low Dose Naltrexone (LDN).
|
Researcher
|
Areas of Research
|
 |
Ian S. Zagon Ph.D.
Distinguished Professor, Distinguished Educator, and Director of the Program on Education in Human Structure
Hershey Medical Center, Penn State University College of Medicine
|
LDN in animal models of Multiple Sclerosis; Mechanism of Action of LDN in Multiple Sclerosis; Mechanism of Action of LDN in autoimmune disorders, Mechanism of Action of LDN in Parkinson’s disease.
Learn more about Dr. Zagon >>
|
 |
Patricia J. McLaughlin Ph.D.
Professor of Neural and Behavioral Sciences and Director of the Graduate Program in Anatomy
Hershey Medical Center, Penn State University College of Medicine
|
LDN in animal models of Multiple Sclerosis; Mechanism of Action of LDN in Multiple Sclerosis; Mechanism of Action of LDN in autoimmune disorders, Mechanism of Action of LDN in Parkinson’s disease.
Learn more about Dr. McLaughlin >>
|
 |
Jill P. Smith M.D.
Professor of Medicine
Hershey Medical Center, Penn State University College of Medicine
|
Clinical Trials of LDN for Crohn's disease in adults and in children.
Learn more about Dr. Smith >>
|
|
Moshe Rogosnitzky
Director of Research
MedInsight Research Institute
|
Clinical Trials of LDN for Crohn's disease in adults and in children.
Learn more about Moshe Rogosnitzky >>
|
 |
Jarred Younger Ph.D.
Instructor in Pain Management, Department of Anesthesia
Stanford University School of Medicine
|
Clinical Trials of LDN for Fibromyalgia.
Learn more about Dr. Younger >>
|
 |
Sean Mackey M.D., Ph.D.
Chief, Pain Management Division
Stanford University School of Medicine
|
Clinical Trials of LDN for Fibromyalgia.
Learn more about Dr. Mackey >>
|
|
Maira Gironi M.D.
Institute of Experimental Neurology (INSPE) and Department of Neurology
San Raffaele Scientific Institute, Milan, Italy
|
Clinical Trials of LDN for Multiple Sclerosis.
Learn more about Dr. Gironi >>
|